WC
AGN

Wexford Capital’s Allergan plc AGN Stock Holding History

Wexford Capital’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-3,600
Closed -$756K – 274
2016
Q4 		$756K Buy
+3,600
New +$746K 0.08% 85
2015
Q4 		– Sell
-75,012
Closed -$20.4M – 98
2015
Q3 		$20.4M Buy
+75,012
New +$23M 3.94% 4
2015
Q2 		– Sell
-34,685
Closed -$10.3M – 82
2015
Q1 		$10.3M Buy
34,685
+19,375
+127% +$5.52M 3.01% 8
2014
Q4 		$3.94M Sell
15,310
-31,729
-67% -$7.93M 0.76% 21
2014
Q3 		$11.3M Buy
47,039
+26,039
+124% +$5.83M 1.04% 12
2014
Q2 		$4.68M Sell
21,000
-59,702
-74% -$12.4M 0.35% 35
2014
Q1 		$16.6M Buy
80,702
+14,455
+22% +$2.86M 1.26% 4
2013
Q4 		$11.1M Buy
66,247
+60,247
+1,004% +$9.42M 0.95% 7
2013
Q3 		$864K Sell
6,000
-6,000
-50% -$799K 0.07% 122
2013
Q2 		$1.51M Buy
+12,000
New +$1.36M 0.13% 96

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Wexford Capital's AGN Position: Q1 2017 in Review

Wexford Capital sold out of Allergan plc (AGN) in Q1 2017, closing a stake of 3,600 shares — an estimated $756K sold.

Wexford Capital first reported a position in AGN in Q2 2013 and held it in 10 quarters. The position peaked at $20.4M in Q3 2015. 1,104 funds tracked by Wall St. Rank hold AGN as of Q1 2017.

  • Wexford Capital reported no remaining Allergan plc position as of Q1 2017 after selling out during the quarter.
  • Wexford Capital sold 3,600 Allergan plc shares in Q1 2017, an estimated $756K.
  • Wexford Capital first reported a position in Allergan plc in Q2 2013 and held it in 10 quarters.
  • Wexford Capital's Allergan plc position peaked at $20.4M in Q3 2015.
  • 1,104 funds tracked by Wall St. Rank held Allergan plc as of Q1 2017.

Based on Wexford Capital's 13F filing for Q1 2017, filed 12 May 2017.